This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_FLOOROFMOUTH_EXALLC for full statistics.
Malignant neoplasm of floor of mouth
C3_FLOOROFMOUTH
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
166 |
4. Check minimum number of eventsNone |
166 |
5. Include endpointsNone |
166 |
6. Filter based on genotype QC (FinnGen only) |
166 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 5
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of floor of mouth
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of oral cavity
- Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 166 | 53 | 113 |
| Unadjusted period prevalence (%) | 0.04 | 0.02 | 0.05 |
| Median age at first event (years) | 63.56 | 64.55 | 63.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 154
- Matched controls
- 1538
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8070/3-C04.9
ICD-O-3
Squamous cell carcinoma, NOS, of floor of mouth, NOS
+∞
117.1
97
*
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
+∞
100.3
85
*
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
+∞
86.9
75
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
132.4
84.0
85
14
GBB00
NOMESCO Finland
Tracheostomy
200.2
69.7
68
6
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
134.9
57.9
59
7
JDB10
NOMESCO Finland
Percutaneous gastrostomy
155.2
51.6
52
5
C04.1
ICD-10 Finland
Malignant neoplasm: Lateral floor of mouth
+∞
48.5
44
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
583.7
45.8
43
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
166.7
37.6
38
*
EDB00
NOMESCO Finland
Partial excision of mandible
+∞
35.8
33
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
12.3
35.3
72
102
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
9.2
35.2
109
320
C04.9
ICD-10 Finland
Malignant neoplasm: Floor of mouth, unspecified
+∞
34.7
32
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
149.7
34.3
35
*
130
Kela drug reimbursment
Malignant tumour
13.1
34.1
66
83
WF003
NOMESCO Finland
Adjuvant radiotherapy
28.3
32.9
45
22
EP1AE
NOMESCO Finland
Neck ultrasound examination
19.4
32.0
50
37
C04.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of floor of mouth
+∞
29.1
27
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
20.0
28.8
44
30
SAA03
NOMESCO Finland
Extended examination of mouth
7.2
28.6
105
352
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
39.1
27.3
34
11
SBB10
NOMESCO Finland
Teeth copy
17.6
26.8
43
33
EJB60
NOMESCO Finland
Partial excision of floor of mouth
+∞
24.6
23
*
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
282.1
24.4
24
*
A07AA02
ATC
nystatin; oral
13.4
23.8
43
43
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
42.3
23.0
28
8
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
70.5
21.6
24
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
21.6
20.6
30
17
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
15.2
20.3
34
28
8070/3-C04.0
ICD-O-3
Squamous cell carcinoma, NOS, of anterior floor of mouth
+∞
20.2
19
*
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
24.1
19.9
28
14
EBA15
NOMESCO Finland
Extraction of large number of teeth
11.6
18.4
35
38
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
202.3
17.9
18
*
EBB10
NOMESCO Finland
Insertion of dental implant
29.7
17.5
23
9
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
9.4
17.3
37
50
XX3DW
NOMESCO Finland
Time consuming IT work
7.0
17.2
46
88
EBA10
NOMESCO Finland
Surgical removal of tooth
8.3
16.8
39
60
EBB15
NOMESCO Finland
Insertion of dental implant abutment
53.8
16.4
19
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
53.8
16.4
19
*
SXC03
NOMESCO Finland
Other oral or dental procedure
67.4
16.1
18
*
ZZA00
NOMESCO Finland
Split skin graft
18.7
15.9
24
15
ECA20
NOMESCO Finland
Biopsy of gingiva
42.9
15.8
19
5
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
15.5
15.3
25
19
K13.78
ICD-10 Finland
Other change in the oral mucosa
24.0
15.1
21
10
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
9.5
14.4
30
38
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.6
14.4
59
183
TJD20
NOMESCO Finland
Change of gastrostomy tube
59.1
14.1
16
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
15.8
13.7
22
16
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
23.8
13.7
19
9
N02AA05
ATC
oxycodone; systemic
4.7
13.7
54
160
K13.29
ICD-10 Finland
Indefinite leukoplakia
44.2
13.4
16
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
35.4
12.8
16
5
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
76.3
12.8
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
12.7
68
263
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
+∞
12.7
12
*
8070/3-C04.1
ICD-O-3
Squamous cell carcinoma, NOS, of lateral floor of mouth
+∞
12.7
12
*
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
8.1
12.3
28
41
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.5
12.1
29
46
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
51.0
12.1
14
*
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
51.0
12.1
14
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
8.7
12.1
26
35
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
6.5
11.9
32
60
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
25.3
11.8
16
7
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.4
11.7
86
417
EJW99
NOMESCO Finland
Other operation on tongue or floor of mouth
+∞
11.6
11
*
EJC99
NOMESCO Finland
Other reconstructive operations on tongue and floor of mouth
+∞
11.6
11
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
9.8
11.5
23
27
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
38.2
11.5
14
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
8.0
11.5
26
38
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
22.1
11.4
16
8
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
27.5
11.4
15
6
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
47.0
11.1
13
*
SXC05
NOMESCO Finland
Other oral or dental procedure
7.4
10.6
25
39
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
10.5
10
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
10.5
10
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
10.5
10
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.7
10.5
54
196
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
25.5
10.4
14
6
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
11.2
10.4
19
19
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
21.8
10.0
14
7
SXA10
NOMESCO Finland
Epithel biopsy of mouth
28.2
10.0
13
5
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.1
9.9
24
39
SBA00
NOMESCO Finland
Microbiological examinations
16.4
9.7
15
10
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
32.3
9.6
12
*
UJC01
NOMESCO Finland
Scopy of lower throat
23.5
9.5
13
6
EJB99
NOMESCO Finland
Other excision on tongue and floor of mouth
+∞
9.5
9
*
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
+∞
9.5
9
*
EBA00
NOMESCO Finland
Extraction of tooth
3.1
9.4
66
297
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
9.3
9.4
19
23
SPD05
NOMESCO Finland
Demanding fitting of total teeth prosthesis
39.2
9.1
11
*
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
20.1
9.1
13
7
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
10.5
9.0
17
18
WX110
NOMESCO Finland
Local anesthesy
3.0
8.9
114
750
QAB05
NOMESCO Finland
Revision of wound of skin of head or neck
53.1
8.8
10
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
21.5
8.6
12
6
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
29.4
8.6
11
*
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
29.4
8.6
11
*
R13
ICD-10 Finland
Dysphagia
5.5
8.6
25
52
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
11.7
8.5
15
14
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
95.0
8.5
9
*
GD6AD
NOMESCO Finland
CT of chest and neck
95.0
8.5
9
*
D83
ICPC
Mouth/tongue/lip disease
95.0
8.5
9
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
8.4
8
*
WX707
NOMESCO Finland
Fiberoscopic intubation
+∞
8.4
8
*
EDB20
NOMESCO Finland
Hemimandibulectomy
+∞
8.4
8
*
D10.2
ICD-10 Finland
Benign neoplasm: Floor of mouth
+∞
8.4
8
*
J02AC01
ATC
fluconazole; systemic
2.9
8.4
64
302
N07BA03
ATC
varenicline; oral
6.2
8.4
22
40
K05.31
ICD-10 Finland
Periodontitis pronounced
4.5
8.3
30
79
EKA10
NOMESCO Finland
Biopsy of cheek
9.8
8.3
16
18
EB1WA
NOMESCO Finland
NA
35.4
8.2
10
*
R4190
NOMESCO Finland
Nutritional therapy
8.5
8.1
17
22
SPF30
NOMESCO Finland
Soling for prothesis
11.7
8.0
14
13
N05AA02
ATC
levomepromazine; systemic
8.2
7.9
17
23
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
47.4
7.8
9
*
ECB20
NOMESCO Finland
Oral alveoplasty
19.6
7.7
11
6
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
5.1
7.7
24
54
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
7.5
7.5
17
25
EDW99
NOMESCO Finland
Other operation on mandible
84.0
7.5
8
*
R4130
NOMESCO Finland
Speech therapy
11.7
7.5
13
12
JDB00
NOMESCO Finland
Gastrostomy
+∞
7.3
7
*
EJB40
NOMESCO Finland
Hemiglossectomy
+∞
7.3
7
*
EDC42
NOMESCO Finland
Mandibular repair with implant
+∞
7.3
7
*
C06.9
ICD-10 Finland
Malignant neoplasm: Mouth, unspecified
+∞
7.3
7
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
+∞
7.3
7
*
SPF20
NOMESCO Finland
Temporary soling for filling
16.8
7.3
11
7
Z50.5
ICD-10 Finland
Speech therapy
21.2
7.2
10
5
SPD01
NOMESCO Finland
Mucosa-supported complete denture
21.2
7.2
10
5
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
31.6
7.2
9
*
Z51.5
ICD-10 Finland
Palliative care
4.8
7.1
23
54
N05AB01
ATC
dixyrazine; systemic
14.7
7.0
11
8
ZX070
NOMESCO Finland
Intensity modified radiotherapy
11.7
6.9
12
11
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
11.7
6.9
12
11
GD1AD
NOMESCO Finland
Thorax CT examination
5.1
6.9
21
46
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.6
6.9
23
56
D20
ICPC
Mouth/tongue/lip symptom/complaint
7.0
6.8
16
25
WX872
NOMESCO Finland
Intensive care
5.0
6.8
21
47
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
23.7
6.8
9
*
WX402
NOMESCO Finland
General anaesthesia
3.1
6.7
40
156
SAA01
NOMESCO Finland
Simple examination of mouth
2.5
6.5
107
738
SPA60
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 1 to 3 units
15.2
6.5
10
7
A04AD12
ATC
aprepitant; systemic
15.2
6.5
10
7
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
6.2
6.3
16
28
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
27.9
6.3
8
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
27.9
6.3
8
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
+∞
6.3
6
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
+∞
6.3
6
*
SCB02
NOMESCO Finland
Training for mouth care at home
+∞
6.3
6
*
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
+∞
6.3
6
*
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
10.7
6.1
11
11
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
10.7
6.1
11
11
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
10.7
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
73
133
9.01
42.81
2.6
2.5
g/l
0.2
0.2
0.83
73
122
(3026389) Candida sp identified in Specimen by Organism specific culture
21
15
15.88
23.20
1.9
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
21
25
9.47
16.64
1.2
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
52
154
4.46
16.47
1.8
1.6
—
—
—
0
0
(4035726)
47
132
4.57
15.89
1.6
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
103
524
3.54
14.21
3.5
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
48
155
3.95
13.27
1.5
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
6
31.30
13.25
6.4
2.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
56
208
3.55
12.51
1.9
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
106
609
3.05
10.84
5.4
4.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
81
408
2.92
10.46
4.8
4.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
100
586
2.78
9.36
7.2
8.6
inr
1.0
1.2
3.92
25
178
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
108
662
2.81
9.20
8.8
6.6
mmol/l
1.2
1.2
2.06
91
554
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
38
132
3.44
9.18
2.5
1.9
%
2.4
1.6
1.80
31
111
(3044640) Blood type and Crossmatch panel - Blood
78
422
2.60
8.31
3.5
2.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
47
216
2.64
6.79
1.9
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
62
327
2.43
6.69
3.2
2.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
71
406
2.31
6.31
3.5
4.5
ph
7.4
7.4
0.06
18
84
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
22
69
3.52
6.13
12.8
8.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
107
745
2.23
5.67
11.9
10.4
e9/l
4.8
4.3
1.32
95
654
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
102
2.97
5.57
2.3
3.3
ml/min/173m2
73.2
60.5
—
10
47
(3003694) ABO and Rh group [Type] in Blood
56
304
2.27
5.50
1.5
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
77
496
2.03
4.73
2.4
2.2
nmol/l
77.0
77.3
0.03
69
431
(3019060) Gas panel - Arterial blood
25
99
2.80
4.73
10.2
4.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
28
118
2.65
4.71
10.1
6.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
19
438
0.36
4.46
2.5
3.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
37
185
2.29
4.32
8.5
6.2
mmol/l
103.1
103.7
0.27
37
180
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
41
3.64
4.29
1.4
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
92
649
1.94
4.20
5.6
5.6
e9/l
0.0
0.0
0.15
81
554
(3001604) Monocytes [#/volume] in Blood
92
649
1.94
4.20
5.5
5.6
e9/l
0.6
0.6
0.41
78
549
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
23
4.56
4.15
1.1
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
93
661
1.93
4.13
5.9
5.8
e9/l
0.2
0.2
0.04
82
575
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
22
88
2.73
4.08
9.5
5.3
mmol/l
25.9
24.6
1.10
22
88
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
23
95
2.65
4.01
1.9
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
68
440
1.92
3.97
6.0
5.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
151
2.29
3.83
1.9
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
40
218
2.10
3.75
2.0
1.7
s
29.3
29.8
0.26
40
208
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
31
153
2.26
3.71
2.2
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
91
665
1.82
3.49
5.6
5.7
e9/l
1.5
1.8
1.98
79
580
(40758558) Short blood count panel - Blood
52
319
1.92
3.49
11.9
7.2
—
—
—
0
0
(3002256) Pathology report gross observation
32
165
2.16
3.44
1.4
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
86
620
1.80
3.44
6.7
5.8
%
20.5
26.4
4.68
80
577
(3020891) Body temperature
15
57
2.79
3.06
8.9
4.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
13
46
2.98
2.99
9.5
3.3
mmol/l
4.1
3.9
0.46
13
41
(3026782) Osmolality of Urine
45
282
1.82
2.77
3.0
3.2
mosm/kgh2o
485.0
569.8
1.84
38
236
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
109
1274
0.58
2.69
3.9
4.8
mmol/l
1.4
1.4
0.08
101
1159
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
25
3.74
2.61
1.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
25
3.74
2.61
1.1
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
44
282
1.76
2.49
2.1
2.9
e6/l
3.8
4.3
0.22
38
249
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
39
584
0.57
2.49
5.2
4.2
%
16.2
21.2
0.82
17
287
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
79
2.28
2.34
1.6
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
111
1278
0.60
2.32
4.0
4.9
mmol/l
4.4
4.5
0.56
104
1174
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
13
4.74
2.29
1.0
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
73
548
1.59
2.23
1.9
2.0
pmol/l
76.9
91.7
2.06
39
291
(3004451) EKG impression Narrative
5
9
5.69
2.23
1.4
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
60
430
1.62
2.22
3.1
3.4
e6/l
78.3
188.3
0.30
47
324
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
18
88
2.17
2.21
1.7
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
53
716
0.62
2.17
4.8
5.0
ug/l
2.3
2.7
0.29
46
639
(46235355) HIV 1 and 2 tests - Meaningful Use set
25
140
1.93
2.16
1.2
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
25
3.31
2.12
1.1
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
65
483
1.57
2.04
4.1
4.0
e6/l
16.4
44.4
2.27
50
346
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
32
2.91
2.03
1.7
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
32
2.91
2.03
1.7
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
51
2.46
2.00
1.4
2.0
—
—
—
0
0
(4010399)
19
101
2.00
1.90
1.4
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
52
374
1.57
1.86
2.4
3.2
—
—
—
0
0
(3000492) Spirometry study
19
102
1.97
1.85
1.3
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
21
119
1.88
1.76
1.5
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
42
2.47
1.71
1.2
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
54
399
1.52
1.69
2.5
3.3
e6/l
0.3
0.4
0.50
43
292
(3029937) Albumin [Presence] in Urine by Test strip
47
337
1.55
1.69
4.8
3.9
estimate
0.0
0.0
0.00
15
125
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
49
2.33
1.67
1.3
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
21
122
1.83
1.64
2.8
4.9
%
1.0
1.2
—
7
47
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
43
2.41
1.63
1.6
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
65
503
1.48
1.63
3.3
3.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
14
3.65
1.62
1.0
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
32
2.57
1.62
1.8
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
20
116
1.82
1.57
1.3
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
21
2.92
1.52
4.0
2.1
e9/l
5.1
5.3
—
6
21
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
25
157
1.70
1.51
7.2
4.8
u/l
356.5
234.2
0.42
25
151
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
118
1306
0.67
1.50
4.3
5.5
mmol/l
2.5
2.7
1.08
110
1188
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
37
2.51
1.50
2.0
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
22
2.79
1.45
4.0
3.0
%
63.2
63.5
—
6
22
(3013707) Erythrocyte sedimentation rate by Westergren method
110
955
1.45
1.44
4.7
4.2
mm/h
19.1
12.7
2.26
104
868
(3044889) 12 lead EKG panel
111
966
1.45
1.43
4.8
4.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
39
278
1.53
1.43
4.2
3.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
24
153
1.66
1.38
6.4
3.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
23
2.67
1.38
1.7
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
25
162
1.64
1.36
17.4
8.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
19
114
1.75
1.35
2.3
5.0
%
0.0
0.2
—
6
42
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
112
1243
0.70
1.33
3.6
4.3
mmol/l
1.3
1.3
0.09
102
1127
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
18
2.83
1.29
2.8
1.7
ug/l
15.0
19.8
—
5
18
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
20
124
1.70
1.28
2.8
2.7
ug/l
8.7
7.8
0.07
20
112
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
105
915
1.40
1.27
4.9
3.7
pmol/l
14.8
15.0
0.46
100
807
(44790048)
5
19
2.68
1.22
1.8
1.5
—
—
—
0
0
(44790047)
5
19
2.68
1.22
1.8
1.5
—
—
—
0
0
(44806118)
5
19
2.68
1.22
1.8
1.5
—
—
—
0
0
(44790049)
5
19
2.68
1.22
1.8
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
26
368
0.65
1.19
5.2
3.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
19
119
1.67
1.18
4.7
4.8
mmol/l
1.2
1.2
0.52
19
106
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
39
2.10
1.17
1.5
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
35
0.00
1.16
0.0
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
20
2.54
1.16
2.8
4.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
71
588
1.36
1.14
13.4
11.2
e9/l
0.0
0.0
0.24
61
482
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
32
230
1.48
1.13
3.0
3.0
e6/l
1.7
1.2
0.24
18
127
(3002179) Metamyelocytes/100 leukocytes in Blood
17
105
1.69
1.11
2.5
5.1
%
0.6
0.4
—
5
30
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
10
52
1.98
1.08
1.0
1.1
—
203.6
—
0
16
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
77
1.75
0.98
1.7
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
44
1.86
0.87
1.3
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
32
243
1.39
0.86
2.2
2.8
e6/l
0.9
0.9
0.05
18
141
(3025941) Bacteria identified in Stool by Culture
11
66
1.71
0.81
1.6
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
26
0.00
0.79
0.0
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
16
108
1.53
0.77
2.1
2.8
kpa
4.7
4.4
0.27
16
103
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
39
1.83
0.73
1.6
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
25
2.03
0.73
1.6
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
33
261
1.33
0.70
1.8
1.6
mg/l
1.1
1.5
0.66
27
215
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
27
1.88
0.69
1.2
1.5
—
—
—
0
0
(3019225) pH of Specimen
18
129
1.44
0.67
4.2
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
44
368
1.27
0.62
3.5
3.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
30
1.69
0.62
1.2
2.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
32.7
—
0
7
(3008898) HLA-B27 [Presence]
0
22
0.00
0.60
0.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
13
183
0.69
0.59
3.4
4.8
%
32.9
32.1
—
8
121
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
53
1.53
0.59
4.0
2.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
34
277
1.29
0.59
6.4
5.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
8
54
1.51
0.58
1.3
1.2
u/ml
280.0
176.0
—
8
46
(40761535) Cells panel - Urine sediment
14
99
1.45
0.56
4.0
3.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
37
1.64
0.56
1.7
1.2
—
3.3
—
0
6
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
39
1.56
0.53
1.7
1.2
—
1.9
—
0
7
(3027315) Oxygen [Partial pressure] in Blood
6
40
1.52
0.52
6.2
3.1
kpa
8.1
8.2
—
6
40
(3013290) Carbon dioxide [Partial pressure] in Blood
6
40
1.52
0.52
6.2
3.1
kpa
4.8
5.0
—
6
40
(3012501) Base excess in Blood by calculation
6
40
1.52
0.52
6.2
3.1
mmol/l
2.3
2.5
—
6
26
(3020682) Albumin/Creatinine [Ratio] in Urine
39
456
0.81
0.50
3.8
4.0
mg/mmol
11.5
8.6
0.26
25
288
(3012516) Albumin [Mass/volume] in Urine
37
431
0.82
0.46
2.7
3.2
mg/l
1592.6
357.2
0.37
26
281
(3023520) Reticulocytes [#/volume] in Blood
17
130
1.34
0.46
2.0
2.7
e9/l
71.3
66.2
0.22
12
105
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
122
1278
0.83
0.45
4.1
4.9
mmol/l
6.1
6.1
0.17
115
1162
(40761536) Microorganisms panel - Urine sediment
15
113
1.36
0.44
5.1
4.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
35
297
1.23
0.44
1.5
1.8
pmol/l
506.9
460.2
0.22
27
251
(3035941) MCH [Entitic mass]
137
1419
0.80
0.44
43.1
22.8
pg
31.1
30.5
3.40
137
1401
(3000963) Hemoglobin [Mass/volume] in Blood
137
1419
0.80
0.44
43.5
23.0
g/l
123.1
136.6
15.02
137
1399
(3021601) Nitrite [Presence] in Urine by Test strip
70
635
1.18
0.44
5.1
5.0
estimate
0.0
0.0
0.00
17
131
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
70
1.46
0.43
1.5
2.7
%
1.5
1.2
—
10
70
(3024731) MCV [Entitic volume]
137
1418
0.81
0.42
43.1
22.8
fl
93.5
91.5
5.08
137
1400
(3021447) Carbon dioxide [Partial pressure] in Venous blood
17
132
1.32
0.42
2.3
3.6
kpa
5.9
5.7
0.27
17
127
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
33
1.53
0.41
1.2
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(4146454)
0
15
0.00
0.41
0.0
2.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
34
1.48
0.40
4.4
3.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
18
0.00
0.40
0.0
1.1
—
8.1
—
0
11
(3009261) Glucose [Presence] in Urine by Test strip
70
639
1.17
0.40
4.4
3.7
estimate
0.0
0.0
0.00
17
120
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
20
161
1.28
0.39
2.2
5.5
ug/l
6.3
35.5
0.61
20
139
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
119
1244
0.85
0.39
5.1
6.4
mmol/mol
40.0
40.9
0.34
110
1156
(3035350) Ketones [Presence] in Urine by Test strip
69
634
1.15
0.35
4.5
3.6
estimate
0.0
0.0
0.00
14
131
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
68
628
1.14
0.32
2.1
2.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
(3012544) pH of Venous blood
16
133
1.22
0.25
2.4
3.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
39
1.29
0.23
1.2
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
10
124
0.79
0.22
1.3
3.1
g/l
63.7
67.1
—
10
112
(3019832) Treponema pallidum Ab [Presence] in Serum
5
42
1.20
0.21
1.0
1.7
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4268621)
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(4281824)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
12
0.00
0.21
0.0
1.7
—
3.5
—
0
6
(4306422)
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
4.4
—
97.7
—
0
12
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
60
1.17
0.18
1.3
2.2
u/l
41.4
36.4
—
7
53
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
69
0.72
0.17
2.8
2.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
14
162
0.85
0.17
1.4
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
21
234
0.88
0.16
1.1
1.4
g/l
3.1
2.7
0.57
16
136
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
6
78
0.76
0.16
1.3
1.3
—
30.1
—
0
6
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
22
244
0.89
0.16
1.2
1.2
u/ml
0.8
1.5
—
10
72
(40768797) Stomach Pathology biopsy report
20
179
1.13
0.15
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
41
436
0.92
0.14
2.7
3.1
mmol/l
6.1
7.7
1.57
36
354
(3004588) Protein electrophoresis panel - Serum or Plasma
9
107
0.83
0.13
1.1
2.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
19
209
0.90
0.12
1.2
1.3
iu/ml
32.1
36.4
—
8
72
(3005719) IgG [Mass/volume] in Serum or Plasma
11
95
1.17
0.12
4.8
2.1
g/l
8.2
10.1
0.74
11
83
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
20
182
1.11
0.11
1.1
1.3
u/ml
1.3
8.5
—
10
69
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
57
594
0.94
0.11
4.7
4.1
ng/l
49.7
45.1
0.09
49
449
(3009445) Proteinase 3 Ab [Units/volume] in Serum
6
54
1.12
0.09
1.2
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
91
889
1.05
0.09
4.9
4.2
—
—
—
0
0
(3013512) EKG study
43
449
0.94
0.09
3.8
4.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
118
1162
1.05
0.08
5.7
4.4
mu/l
2.3
2.0
0.76
110
1035
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
73
1.10
0.07
1.4
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
7
83
0.84
0.07
1.0
1.7
g/l
2.5
1.6
—
7
75
(3022621) pH of Urine by Test strip
7
84
0.83
0.07
2.9
2.0
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
9
86
1.05
0.07
1.8
3.1
g/l
123.7
129.1
—
9
86
(3020564) Creatinine [Moles/volume] in Serum or Plasma
137
1383
0.95
0.05
34.2
19.1
umol/l
73.3
82.4
3.08
137
1383
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
121
1.08
0.04
1.4
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
139
0.93
0.03
1.2
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
124
1250
0.97
0.03
26.0
15.0
ml/min/173m2
85.3
76.9
4.44
112
1046
(40761511) CBC panel - Blood by Automated count
133
1339
0.97
0.02
28.3
14.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
50
494
1.02
0.00
5.1
3.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
107
1066
1.01
0.00
33.8
19.0
%
14.2
13.7
2.62
107
1049
(3023103) Potassium [Moles/volume] in Serum or Plasma
137
1369
1.00
0.00
34.4
18.3
mmol/l
4.0
4.0
0.54
137
1342
(3009542) Hematocrit [Volume Fraction] of Blood
111
1112
0.99
0.00
30.2
16.0
%
36.1
40.1
4.21
62
758
(3019550) Sodium [Moles/volume] in Serum or Plasma
137
1365
1.02
0.00
35.2
18.2
mmol/l
138.0
139.7
8.49
137
1334
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
7.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
58
0.86
0.00
1.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
7.1
—
0
7
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4024509)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
1.2
—
0
5
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
5
50
1.00
0.00
1.6
4.8
—
3.5
—
0
7
(3024263) Appearance of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
29.0
—
0
6
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
9
90
1.00
0.00
1.4
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
2.8
—
13.4
—
0
6
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
63.4
—
0
8
(3010375) cycloSPORINE [Mass/volume] in Blood
0
5
0.00
0.00
0.0
39.2
—
95.2
—
0
5
(3022313) Gas panel - Capillary blood
6
68
0.88
0.00
2.2
3.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
7
70
1.00
0.00
2.4
3.8
%
53.0
45.2
—
7
70
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
4.5
—
54.2
—
0
6
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
65
0.92
0.00
1.2
1.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
6
66
0.91
0.00
2.3
3.4
mmol/l
24.1
24.5
—
6
66
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
13.1
—
0
5
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
12.4
—
0
5
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(4027681)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.0
—
215.6
—
0
5
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
9.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
6
59
1.02
0.00
2.5
3.6
pmol/l
4.0
4.6
—
6
50
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_FLOOROFMOUTH – Malignant neoplasm of floor of mouth
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).